Stock Mumak

Stock Profile

Johnson & Johnson

Thanks to a strong pipeline, robust cash flows and a defensive business model, Johnson & Johnson remains a high-quality healthcare investment.

Stock Snapshot

JNJ Logo
Table HeaderTable Header
CompanyJohnson & Johnson
SectorHealthcare
ThemePharma & Medical Technology
Business ModelDevelopment and marketing of innovative pharmaceuticals and medical technology
ISINUS4781601046
Market Capitalizationapprox. USD 645.9 billion
UMBRELLA StatusActive
  • Geopolitics
  • Industry
  • Fundamentals
  • Sentiment
  • Technical Analysis

Price Performance (12 Months)

Aktuelle Unternehmensmeldungen

Latest Portfolio Updates

Weekly Update

Weekly Market Overview – August 31-September 6, 2026

UMBRELLA strategy: Focus continues to shift toward healthcare and advanced technologies
Next Update
MUMAK SpotLight

MUMAK SpotLight of the week: Eli Lilly and Palantir in focus

Eli Lilly strengthens its pipeline, Palantir remains volatile, and Johnson & Johnson gains momentum. The most important developments of the
Next Update
PayPal
Company Update

PayPal Update: Is the stock stabilizing after the sell-off?

PayPal is recovering after the sell-off. The chart, analyst consensus, and fundamental development show initial signs of stabilization.
Next Update
Palantir
Company Update

Palantir Update: What’s behind the volatility?

Following the strong August rally, Palantir is seeing pronounced price swings. Strong growth meets a high valuation and elevated market
Next Update